PLUS1
7.18
-0.38 (-5.03%)
-0.38 (-5.03%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.38 | -5.03% | 7.18 | 19:59:38 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.58 | 7.07 | 7.62 | 7.23 | 7.56 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.15 | 7.18 | 0.03 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 45,827 | 12,673,836 | $ 7.27 | $ 92,172,904 | 14,918,063 | 1.52 - 21.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:38 | formt | 1,000 | $ 7.18 | USD |
Sorrento Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.89B | 262.94M | 258.15M | $ 31.43M | $ - | -2.20 | -5.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sorrento Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/17/2020 | 06:05 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/11/2020 | 09:00 | GlobeNewswire Inc. | Sorrento Announces IND Filing for COVI-DROPS, an Intranasal.. |
| 11/09/2020 | 09:00 | GlobeNewswire Inc. | Sorrento Announces FDA IND Filing Today for COVI-AMG.. |
| 11/09/2020 | 06:02 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 10/29/2020 | 09:01 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/29/2020 | 09:00 | GlobeNewswire Inc. | Sorrento Announces That Intranasal Administration of.. |
| 10/22/2020 | 17:26 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.40 | 7.90 | 6.22 | 7.17 | 13,106,747 | 0.78 | 12.19% |
| 1 Month | 7.99 | 8.17 | 5.17 | 6.75 | 13,202,601 | -0.81 | -10.14% |
| 3 Months | 8.17 | 12.31 | 5.17 | 8.78 | 21,234,287 | -0.99 | -12.12% |
| 6 Months | 5.91 | 21.26 | 3.82 | 9.44 | 30,801,939 | 1.27 | 21.49% |
| 1 Year | 2.20 | 21.26 | 1.52 | 7.89 | 23,247,108 | 4.98 | 226.36% |
| 3 Years | 2.25 | 21.26 | 1.39 | 7.46 | 9,160,178 | 4.93 | 219.11% |
| 5 Years | 7.74 | 21.26 | 1.39 | 7.32 | 5,715,147 | -0.56 | -7.24% |
Sorrento Therapeutics Description
| Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates. |
